4/A
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001780660-26-000002
Chief People Officer sold 4,394 shares at $17.50 ($76,895)
- Chief People Officer acquired 4,394 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
LO FRANCIS · Chief People Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-22 | Exercise or conversion : show line 1 in the form 10b5-1 | +1,100 | $7.80 | $8,580 | 317,078 | D |
| 2025-12-22 | Exercise or conversion : show line 2 in the form 10b5-1 | +1,100 | $8.46 | $9,306 | 318,178 | D |
| 2025-12-22 | Exercise or conversion : show line 3 in the form 10b5-1 | +2,194 | $3.99 | $8,754 | 320,372 | D |
| 2025-12-22 | Sale : show line 4 in the form 10b5-1 | −4,394 | $17.50 | $76,895 | 315,978 | D |
| Open-market sales · 4,394 sh · avg $17.50 · $76,895 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-22 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (right to buy) | −1,100 | 112,150 | D |
| 2025-12-22 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (right to buy) | −1,100 | 108,076 | D |
| 2025-12-22 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (right to buy) | −2,194 | 107,981 | D |
Loading xslF345X05/primary_doc.xml…